Zydiwon K Lotion is a topical pharmaceutical formulation containing Beclometasone dipropionate (0.025% w/v), a potent corticosteroid, combined with Ketoconazole (2% w/v), an effective antifungal agent. This combination is indicated for the treatment of inflammatory dermatoses complicated by fungal infections, such as seborrheic dermatitis, tinea corporis, and other superficial mycoses with associated inflammation and pruritus. Beclometasone exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses, thereby reducing erythema, edema, and itching. Ketoconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and fungal cell death. Zydiwon K Lotion is applied topically to the affected area once or twice daily, as directed by a healthcare professional, ensuring the skin is clean and dry prior to application. Treatment duration should be limited to avoid potential corticosteroid-related side effects such as skin atrophy or systemic absorption. Caution is advised in patients with hypersensitivity to any component, and use on large areas or broken skin should be avoided. This combination therapy offers a synergistic approach to managing inflammatory fungal skin conditions effectively.